280 related articles for article (PubMed ID: 27891816)
1. DLL4 overexpression increases gastric cancer stem/progenitor cell self-renewal ability and correlates with poor clinical outcome via Notch-1 signaling pathway activation.
Miao ZF; Xu H; Xu HM; Wang ZN; Zhao TT; Song YX; Xu YY
Cancer Med; 2017 Jan; 6(1):245-257. PubMed ID: 27891816
[TBL] [Abstract][Full Text] [Related]
2. Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway.
Sun HW; Wu C; Tan HY; Wang QS
Hepatogastroenterology; 2012 May; 59(115):924-9. PubMed ID: 22020917
[TBL] [Abstract][Full Text] [Related]
3. Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells.
Li GG; Li L; Li C; Ye LY; Li XW; Liu DR; Bao Q; Zheng YX; Xiang DP; Chen L; Chen J
World J Gastroenterol; 2013 Jul; 19(28):4486-94. PubMed ID: 23901223
[TBL] [Abstract][Full Text] [Related]
4. Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme.
El Hindy N; Keyvani K; Pagenstecher A; Dammann P; Sandalcioglu IE; Sure U; Zhu Y
Neuro Oncol; 2013 Oct; 15(10):1366-78. PubMed ID: 23787764
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal milky spots serve as a hypoxic niche and favor gastric cancer stem/progenitor cell peritoneal dissemination through hypoxia-inducible factor 1α.
Miao ZF; Wang ZN; Zhao TT; Xu YY; Gao J; Miao F; Xu HM
Stem Cells; 2014 Dec; 32(12):3062-74. PubMed ID: 25142304
[TBL] [Abstract][Full Text] [Related]
6. FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4.
McClements L; Annett S; Yakkundi A; O'Rourke M; Valentine A; Moustafa N; Alqudah A; Simões BM; Furlong F; Short A; McIntosh SA; McCarthy HO; Clarke RB; Robson T
BMC Cancer; 2019 Apr; 19(1):351. PubMed ID: 30975104
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer.
Kim DH; Lee S; Kang HG; Park HW; Lee HW; Kim D; Yoem DH; Ahn JH; Ha E; You WK; Lee SH; Kim SJ; Chun KH
BMB Rep; 2020 Nov; 53(10):533-538. PubMed ID: 32580836
[TBL] [Abstract][Full Text] [Related]
8. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
9. Role of Notch signaling pathway in gastric cancer: a meta-analysis of the literature.
Du X; Cheng Z; Wang YH; Guo ZH; Zhang SQ; Hu JK; Zhou ZG
World J Gastroenterol; 2014 Jul; 20(27):9191-9. PubMed ID: 25083094
[TBL] [Abstract][Full Text] [Related]
10. Dll4/Notch1 signalling pathway is required in collective invasion of salivary adenoid cystic carcinoma.
Wang K; Fan HY; Pang X; Zhang M; Yu XH; Wu JS; Chen BJ; Jiang J; Liang XH; Tang YL
Oncol Rep; 2021 Mar; 45(3):1011-1022. PubMed ID: 33469672
[TBL] [Abstract][Full Text] [Related]
11. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth.
Ding XY; Ding J; Wu K; Wen W; Liu C; Yan HX; Chen C; Wang S; Tang H; Gao CK; Guo LN; Cao D; Li Z; Feng GS; Wang HY; Xu ZF
Oncogene; 2012 Jun; 31(23):2899-906. PubMed ID: 22002304
[TBL] [Abstract][Full Text] [Related]
13. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
Cai C; Zhu X
Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of DLL4 expression in gastric cancer.
Ishigami S; Arigami T; Uenosono Y; Okumura H; Kurahara H; Uchikado Y; Setoyama T; Kita Y; Kijima Y; Nishizono Y; Nakajo A; Owaki T; Ueno S; Natsugoe S
J Exp Clin Cancer Res; 2013 Jul; 32(1):46. PubMed ID: 23898884
[TBL] [Abstract][Full Text] [Related]
15. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
[TBL] [Abstract][Full Text] [Related]
16. Mammalian Numb protein antagonizes Notch by controlling postendocytic trafficking of the Notch ligand Delta-like 4.
Shao X; Ding Z; Zhao M; Liu K; Sun H; Chen J; Liu X; Zhang Y; Hong Y; Li H; Li H
J Biol Chem; 2017 Dec; 292(50):20628-20643. PubMed ID: 29042443
[TBL] [Abstract][Full Text] [Related]
17. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
[TBL] [Abstract][Full Text] [Related]
19. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
20. MMGZ01, an anti-DLL4 monoclonal antibody, promotes nonfunctional vessels and inhibits breast tumor growth.
Xu Z; Wang Z; Jia X; Wang L; Chen Z; Wang S; Wang M; Zhang J; Wu M
Cancer Lett; 2016 Mar; 372(1):118-27. PubMed ID: 26739060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
